Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL12, also known as Stromal cell-derived factor 1 (SDF1), is a potent chemoattractant belonging to the CXC chemokine family. It is involved in directing leukocyte migration during immune responses and plays a crucial role in stem cell homing and retention within bone marrow niches, particularly for hematopoietic stem/progenitor cells (HSPCs). CXCL12 interacts primarily with the CXCR4 receptor, mediating chemotaxis and other cellular responses. ACKR3/CXCR7 has also been identified as another binding partner for CXCL12. Dysregulation of CXCL12 signaling has been implicated in cancer progression, metastasis, and hematological disorders. SNPs within the CXCL12 gene are associated with increased risk of coronary artery disease.
CXCL12 binding to CXCR4 induces rapid intracellular calcium fluxes leading to directed cell movement (chemotaxis). The N-terminal Lys-Pro residues are critical for activation of CXCR4; RFFESH motif enhances docking/binding affinity with the receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 12 (CXCL12).